Literature DB >> 29795438

Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.

Raul S Gonzalez1, Justin M M Cates, Chanjuan Shi2.   

Abstract

Mesenteric tumor deposits are an adverse prognostic factor for small intestinal well-differentiated neuroendocrine tumors. Per the American Joint Committee on Cancer (AJCC) Cancer Staging Manual (eighth edition), any mesenteric tumor deposit larger than 2 cm signifies pN2 disease. This criterion has not been critically evaluated as a prognostic factor for small intestinal neuroendocrine tumors, nor have multifocality or histologic features of mesenteric tumor deposits. We evaluated 70 small intestinal neuroendocrine tumors with mesenteric tumor deposits for lesional contour, sclerosis, inflammation, calcification, entrapped blood vessels, and perineural invasion. Ki67 proliferative indices of the largest mesenteric tumor deposit from each case were calculated, and number of tumor deposits and size of the largest deposit were recorded. Associations between these factors (along with patient age, primary tumor Ki67 index, and AJCC stage) and development of liver metastases and overall survival were assessed. Median mesenteric tumor deposit size was 1.5 cm (range: 0.2-7.0 cm); median deposit number was 1 (range: 1-13). Primary and tumor deposit Ki67 indices within a given patient were discordant in 40% of cases but showed similar hazard ratios for disease-specific survival. Size of tumor deposits had no significant effect on prognosis, whether analyzed on a continuous scale or dichotomized using the recommended 2 cm cutoff. In contrast, increasing number of deposits was associated with poor prognosis, with multiple deposits conferring an 8.19-fold risk of disease-specific death compared to a single deposit (P = 0.049). Morphologic features of deposits had no prognostic impact. Size of mesenteric tumor deposits does not affect prognosis in small intestinal neuroendocrine tumor patients; instead, deposit multifocality is associated with shorter disease-specific survival and should be incorporated into future staging criteria.

Entities:  

Mesh:

Year:  2018        PMID: 29795438     DOI: 10.1038/s41379-018-0075-x

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

Review 1.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Peritoneal Carcinomatosis in Well-Differentiated Small-Intestinal Neuroendocrine Tumors with Mesenteric Tumor Deposits.

Authors:  Satya Das; Chanjuan Shi; Tatsuki Koyama; Yi Huang; Raul Gonzalez; Kamran Idrees; Christina Edwards Bailey; Jordan Berlin
Journal:  J Med Surg Pathol       Date:  2019-07-05

3.  Tumor deposit serves as a prognostic marker in gastric cancer: A propensity score-matched analysis comparing survival outcomes.

Authors:  Liang Wenquan; Liu Yuhua; Cui Jianxin; Xi Hongqing; Zhang Kecheng; Li Jiyang; Gao Yunhe; Liu Yi; Zhang Wang; Li Shaoqing; Lu Yixun; Qiao Shen; Xue Wanguo; Qiao Zhi; Chen Lin
Journal:  Cancer Med       Date:  2020-03-12       Impact factor: 4.452

4.  Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer.

Authors:  Xinyue Li; Jing Yang
Journal:  World J Surg Oncol       Date:  2022-02-27       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.